Huixin Biology (300871.SZ) released its first quarter results, turning a loss into a profit of 44.49 million yuan.

Tencent Financial News APP reported that Huisheng Bio (300871.SZ) released its first quarter report for 2025, with the company's operating income reaching 399 million yuan, a year-on-year increase of 92.96%. The net profit attributable to the shareholders of the listed company was 44.497 million yuan. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 34.0907 million yuan. The basic earnings per share was 0.2684 yuan.